Breaking News, Promotions & Moves

Eli Lilly and Co.

Greg Plowman, M.D., Ph.D., has been appointed to lead Lilly’s oncology research efforts as the vice president of oncology research, and senior vice president of ImClone Systems research.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Greg Plowman, M.D., Ph.D., has been appointed to lead Lilly’s oncology research efforts as the vice president of oncology research, and senior vice president of ImClone Systems research. Dr. Plowman will oversee the oncology research efforts of both Lilly and its subsidiary, ImClone, and will be based at ImClone’s Alexandria Center for Life Science in New York City. He reports to Jan Lundberg, Ph.D., executive vice president, science and technology, and president, Lilly Research Laboratories (LR...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters